Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
MIRA Pharmaceuticals, Inc. (MIRA) had Return on Tangible Equity of -269.84% for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.54M |
|
-- |
|
-- |
|
$1.55M |
|
$-1.55M |
|
$0.01M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.54M |
|
$-1.55M |
|
$-1.55M |
|
16.99M |
|
16.99M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$0.83M |
|
-- |
|
$0.04M |
|
$0.87M |
|
$0.30M |
|
-- |
|
-- |
|
$0.30M |
|
$0.57M |
|
$0.57M |
|
$0.57M |
|
17.39M |
|
| Cash Flow Statement Financials | |
$-2.43M |
|
-- |
|
$0.33M |
|
$2.83M |
|
$0.73M |
|
$-2.10M |
|
$1.36M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.79 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-2.43M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-269.84% |
|
|
Return on Tangible Equity |
-269.84% |
-177.09% |
|
-269.84% |
|
$0.03 |
|
$-0.14 |
|
$-0.14 |
|